000142880 001__ 142880
000142880 005__ 20240229112533.0
000142880 0247_ $$2doi$$a10.1097/MPA.0000000000001221
000142880 0247_ $$2pmid$$apmid:30589829
000142880 0247_ $$2ISSN$$a0885-3177
000142880 0247_ $$2ISSN$$a1536-4828
000142880 0247_ $$2altmetric$$aaltmetric:54092863
000142880 037__ $$aDKFZ-2019-00510
000142880 041__ $$aeng
000142880 082__ $$a610
000142880 1001_ $$0P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aWiskemann, Joachim$$b0$$eFirst author$$udkfz
000142880 245__ $$aProgressive Resistance Training to Impact Physical Fitness and Body Weight in Pancreatic Cancer Patients: A Randomized Controlled Trial.
000142880 260__ $$a[s.l.]$$bOvid$$c2019
000142880 3367_ $$2DRIVER$$aarticle
000142880 3367_ $$2DataCite$$aOutput Types/Journal article
000142880 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1551175502_32589
000142880 3367_ $$2BibTeX$$aARTICLE
000142880 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142880 3367_ $$00$$2EndNote$$aJournal Article
000142880 520__ $$aMaintaining or improving muscle mass and muscle strength is an important treatment goal in pancreatic cancer (PC) patients because of high risk of cachexia. Therefore, we assessed feasibility and effectivity of a 6-month progressive resistance training (RT) in PC patients within a randomized controlled trial.Sixty-five PC patients were randomly assigned to either supervised progressive RT (RT1), home-based RT (RT2), or usual care control group (CON). Both exercise groups performed training 2 times per week for 6 months. Muscle strength for knee, elbow, and hip extensors and flexors and cardiorespiratory fitness and body weight were assessed before and after the intervention period.Of 65 patients, 43 patients were analyzed. Adherence rates were 64.1% (RT1) and 78.4% (RT2) of the prescribed training sessions. RT1 showed significant improvements in elbow flexor/extensor muscle strength and in maximal work load versus CON and RT2 (P < 0.05). Further, knee extensors were significantly improved for RT1 versus CON (P < 0.05). Body weight revealed no significant group differences over time.Progressive RT was feasible in PC patients and improved muscle strength with significant results for some muscle groups. Supervised RT seemed to be more effective than home-based RT.
000142880 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142880 588__ $$aDataset connected to CrossRef, PubMed,
000142880 7001_ $$0P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aClauss, Dorothea$$b1$$udkfz
000142880 7001_ $$aTjaden, Christine$$b2
000142880 7001_ $$aHackert, Thilo$$b3
000142880 7001_ $$aSchneider, Lutz$$b4
000142880 7001_ $$aUlrich, Cornelia M$$b5
000142880 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b6$$eLast author$$udkfz
000142880 773__ $$0PERI:(DE-600)2053902-2$$a10.1097/MPA.0000000000001221$$gVol. 48, no. 2, p. 257 - 266$$n2$$p257 - 266$$tPancreas$$v48$$x0885-3177$$y2019
000142880 909CO $$ooai:inrepo02.dkfz.de:142880$$pVDB
000142880 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142880 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f52b77d7ab843c9b900134aafc61638a$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000142880 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000142880 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142880 9141_ $$y2019
000142880 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000142880 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000142880 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142880 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142880 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPANCREAS : 2017
000142880 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142880 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142880 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000142880 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142880 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142880 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000142880 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000142880 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000142880 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000142880 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000142880 980__ $$ajournal
000142880 980__ $$aVDB
000142880 980__ $$aI:(DE-He78)C110-20160331
000142880 980__ $$aUNRESTRICTED